RSNA 2011 

Abstract Archives of the RSNA, 2011


SSK19-06

Endovascular Treatment of Malignant Superior Vena Cava Syndrome: A Comparative Analysis of PTFE-covered Stent and Uncovered Stent

Scientific Formal (Paper) Presentations

Presented on November 30, 2011
Presented as part of SSK19: Vascular/Interventional (Inferior Vena Cava Filters, Venous Interventions, Models)

Participants

Rang Yi, Presenter: Nothing to Disclose
Dong Il Gwon, Abstract Co-Author: Nothing to Disclose
Gi-Young Ko MD, Abstract Co-Author: Nothing to Disclose
Kyu-Bo Sung MD, Abstract Co-Author: Nothing to Disclose
Hyun-Ki Yoon, Abstract Co-Author: Nothing to Disclose
Ji Hoon Shin MD, Abstract Co-Author: Nothing to Disclose
Jin Hyoung Kim MD, Abstract Co-Author: Nothing to Disclose
Jinoo Kim, Abstract Co-Author: Nothing to Disclose
Ho-Young Song MD, Abstract Co-Author: Nothing to Disclose

PURPOSE

To compare the outcomes of polytetrafluoroethylene (PTFE)-covered and uncovered stents in patients with malignant superior vena cava syndrome.

METHOD AND MATERIALS

From October 2008 to December 2010, 21 consecutive patients who underwent PTFE-covered stent placement were prospectively studied. Those data compared with data obtained by retrospectively studying 31 consecutive patients who underwent self-expanding uncovered stent placement from February 2004 to September 2008.

RESULTS

The groups did not differ with regard to age, sex, underlying disease, or location and extent of venous compromise. There were no significant differences in technical success (p > .999) and immediate clinical success (p > .999) between the two groups. There were no complications following stent placement in both groups. According to the Kaplan-Meier analysis, the cumulative stent patency of covered stents was significantly better than that of uncovered stents (p = .039). One patient in the covered stent group developed stent occlusion compared with ten patients in the uncovered stent group, with this difference being significant (Fisher exact test, p = .016). There was no significant difference in the patient survival between the groups (p = .865).

CONCLUSION

PTFE-covered stents were significantly superior to uncovered stents in terms of stent patency for endovascular treatment of patients with malignant superior vena cava syndrome.

CLINICAL RELEVANCE/APPLICATION

PTFE-covered stents were significantly superior to uncovered stents in terms of stent patency for endovascular treatment of patients with malignant superior vena cava syndrome.  

Cite This Abstract

Yi, R, Gwon, D, Ko, G, Sung, K, Yoon, H, Shin, J, Kim, J, Kim, J, Song, H, Endovascular Treatment of Malignant Superior Vena Cava Syndrome: A Comparative Analysis of PTFE-covered Stent and Uncovered Stent.  Radiological Society of North America 2011 Scientific Assembly and Annual Meeting, November 26 - December 2, 2011 ,Chicago IL. http://archive.rsna.org/2011/11011393.html